Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 Aug 22;27(12):1424–1432. doi: 10.1158/1055-9965.EPI-18-0446

Table 2:

Patient-level housing disadvantage by colorectal cancer (CRC) screening test use during 18-month follow-up period for age- and screening-eligible sample (N=32,965)

Overall Screened P-value
N Pct N Pct
(Mean) (SD) (Mean) (SD)
Housing Social Disadvantage
    Log of parcel value per sq. ft.
        T1: −0.71–3.68 ($0.50-$39.58) 10,713 0.33 4,806 0.32 0.02
        T2: 3.68–4.05 ($39.58-$57.40) 11,140 0.34 5,168 0.35
        T3: 4.05–12.96 ($57.40-$423,430) 11,093 0.34 4,889 0.33
    Network distance to clinic (mi) (12.83) (6.38) (12.90) (6.45) 0.86
    # unique addresses per visit1 (0.20) (0.26) (0.12) (0.11) <0.001
    # residence changes/moves per visit1 (0.04) (0.14) (0.03) (0.08) <0.001
    Lived in MFR 5,778 0.18 2,517 0.17 0.04
Total 32,965 1.00 14,863 45.12

Pct: Percent; SD: Standard deviation; IQR: Interquartile mean; Sq.Ft.: Square foot; Mi: Miles; T: Tertiles

1

Measured in 18-month follow-up period.